Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine

Clinical trial NCT01592747 · COMPLETED

Trial details

NCT number: NCT01592747
Sponsor: Forest Laboratories
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Autistic Disorder Autism Asperger's Disorder Asperger Syndrome Autism Spectrum Disorders Pervasive Developmental Disorder - Not Otherwise Specified (PDD-NOS)

Start date: 2012-09-01
Primary completion: 2013-09-01
Enrollment: 479

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.